Free Trial
ASX:ECS

ECS Botanics (ECS) Stock Price, News & Analysis

ECS Botanics logo

About ECS Botanics Stock (ASX:ECS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.99 million shs
Average Volume
N/A
Market Capitalization
A$18.14 million
P/E Ratio
8.31
Dividend Yield
6.22%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ECS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ECS Botanics and its competitors with MarketBeat's FREE daily newsletter.

ECS Stock News Headlines

ECS Botanics Expands with Terphogz Launch in Australia
ECS Botanics Director Increases Stake
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
ECS Botanics Holdings Stock Price History
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:ECS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
8.31
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
A$1.92 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$20.03 million
Price / Cash Flow
5.00
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,290,000,000
Free Float
N/A
Market Cap
A$18.14 million
Optionable
Not Optionable
Beta
1.24
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (ASX:ECS) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners